Bandrés-Ciga Sara, Price Timothy Ryan, Barrero Francisco Javier, Escamilla-Sevilla Francisco, Pelegrina Javier, Arepalli Sampath, Hernández Dena, Gutiérrez Blanca, Cervilla Jorge, Rivera Margarita, Rivera Alberto, Ding Jing-Hui, Vives Francisco, Nalls Michael, Singleton Andrew, Durán Raquel
Department of Physiology and Institute of Neurosciences Federico Olóriz, Centro de Investigaciones Biomedicas (CIBM), University of Granada, Granada, Spain.
Laboratory of Neurogenetics, NIA, NIH, Bethesda, MD, USA.
Neurobiol Aging. 2016 Sep;45:213.e3-213.e9. doi: 10.1016/j.neurobiolaging.2016.06.001. Epub 2016 Jun 11.
Here, we set out to study the genetic architecture of Parkinson's disease (PD) through a Genome-Wide Association Study in a Southern Spanish population. About 240 PD cases and 192 controls were genotyped on the NeuroX array. We estimated genetic variation associated with PD risk and age at onset (AAO). Risk profile analyses for PD and AAO were performed using a weighted genetic risk score. Total heritability was estimated by genome-wide complex trait analysis. Rare variants were screened with single-variant and burden tests. We also screened for variation in known PD genes. Finally, we explored runs of homozygosity and structural genomic variations. We replicate PD association (uncorrected p-value < 0.05) at the following loci: ACMSD/TMEM163, MAPT, STK39, MIR4697, and SREBF/RAI1. Subjects in the highest genetic risk score quintile showed significantly increased risk of PD versus the lowest quintile (odds ratio = 3.6, p-value < 4e(-7)), but no significant difference in AAO. We found evidence of runs of homozygosity in 2 PD-associated regions: one intersecting the HLA-DQB1 gene in 6 patients and 1 control; and another intersecting the GBA-SYT11 gene in PD case. The GBA N370S and the LRRK2 G2019S variants were found in 8 and 7 cases, respectively, replicating previous work. A structural variant was found in 1 case in the PARK2 gene locus. This current work represents a comprehensive assessment at a genome-wide level characterizing a novel population in PD genetics.
在此,我们通过对西班牙南部人群进行全基因组关联研究,着手探究帕金森病(PD)的遗传结构。约240例PD患者和192名对照在NeuroX阵列上进行了基因分型。我们估计了与PD风险和发病年龄(AAO)相关的遗传变异。使用加权遗传风险评分对PD和AAO进行风险概况分析。通过全基因组复杂性状分析估计总遗传力。用单变异和负担检验筛选罕见变异。我们还筛选了已知PD基因的变异。最后,我们探究了纯合子区域和结构基因组变异。我们在以下位点重复了PD关联(未校正p值<0.05):ACMSD/TMEM163、MAPT、STK39、MIR4697和SREBF/RAI1。遗传风险评分最高的五分位数受试者与最低五分位数相比,PD风险显著增加(优势比=3.6,p值<4e(-7)),但AAO无显著差异。我们在2个与PD相关的区域发现了纯合子区域的证据:一个在6例患者和1名对照中与HLA-DQB1基因相交;另一个在PD病例中与GBA-SYT11基因相交。分别在8例和7例病例中发现了GBA N370S和LRRK2 G2019S变异,重复了先前的研究。在PARK2基因位点的1例病例中发现了一个结构变异。这项当前的工作代表了在全基因组水平上对PD遗传学中一个新人群的全面评估。